NIK is a component of the EGF/heregulin receptor signaling complexes

Oncogene

Volumn 22, Issue 28, 2003, Pages 4348-4355

  Chen, Danying ^a   Xu, Liang Guo ^b   Chen, Lei ^a   Li, Lixia ^a   Zhai, Zhonghe ^a   Shu, Hong Bing ^a,b  

^a PEKING UNIVERSITY   (China)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

EGF; Grb7; NF B; NIK; Signaling

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NEU DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; GRB7 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; NF KAPPA B KINASE; NF-KAPPA B KINASE; PROTEIN; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; METABOLISM;

GRB7 ADAPTOR PROTEIN; HUMANS; NEUREGULIN-1; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0042804907     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206532     Document Type: Article

References (41)

1. Akiyama N, Sasaki H, Ishizuka T, Kishi T, Sakamoto H, Onda M, Hirai H, Yazaki Y, Sugimura T and Terada M. (1997). Cancer Res., 57, 3548-3553.
2. Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
3. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
4. Berezia V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J and Burnol AF. (2002). J. Biol. Chem., 277, 4845-4852.
5. Biswas DK, Cruz AP, Gansberger E and Pardee AB. (2000). Proc. Natl. Acad. Sci. USA, 97, 8542-8547.
6. Chen D, Li X, Zhai Z and Shu HB. (2002). J. Biol. Chem., 277, 15985-15991.
7. Daly RJ. (1998). Cell. Signal., 10, 613-618.
8. Daly RJ, Sanderson GM, Janes PW and Sutherland RL. (1996). J. Biol. Chem., 271, 12502-12510.
9. Dong LQ, Du H, Porter SG, Kolakowski Jr LF, Lee AV, Mandarino LJ, Fan J, Yee D, Liu F and Mandarino J. (1997). J. Biol. Chem., 272, 29104-29112.
10. Fiddes RJ, Campbell DH, Janes PW, Sivertsen SP, Sasaki H, Wallasch C and Daly RJ. (1998). J. Biol. Chem., 273, 7717-7724.
11. Frantz JD, Giorgetti-Peraldi S, Ottinger EA and Shoelson SE. (1997). J. Biol. Chem., 272, 2659-2667.
12. Habib AA, Chatterjee S, Park SK, Ratan RR, Lefebvre S and Vartanian T. (2001). J. Biol. Chem., 276, 8865-8874.
13. Han DC and Guan JL. (1999). J. Biol. Chem., 274, 24425-24430.
14. Han DC, Shen TL and Guan JL. (2000). J. Biol. Chem., 275, 28911-28917.
15. Han DC, Shen TL and Guan JL. (2001). Oncogene, 20, 6315-6321.
16. Hill CS and Treisman K. (1995). Cell, 80, 199-211.
17. Hoffmann M, Schmidt M and Wels W. (1998). Cancer Immunol. Immunother., 47, 167-175.
18. Jahn T, Seipel P, Urschel S, Peschel C and Duyster J. (2002). Mol. Cell. Biol., 22, 979-991.
19. Janes PW, Lackmann M, Church WB, Sanderson GM, Sutherland RL and Daly RJ. (1997). J. Biol. Chem., 274, 30896-30905.
20. Lee H, Volonte D, Galbiati F, Lyengar P, Lublin DM, Bregman DB, Milson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE and Lisanti MP. (2000). Mol. Endocrinol., 14, 1750-1755.
21. Lin L, Cao Z and Goeddel DV. (1998a). Proc. Natl. Acad. Sci. USA, 95, 3792-3379.
22. Lin X, Mu Y, Cunningham ET, Marcu KB, Geleziunas R and Greene WC. (1998b). Mol. Cell. Biol., 18, 5899-5907.
23. Liu Z, Hsu H, Goeddel DV and Karin M. (1996). Cell, 87, 565-576.
24. Lyons RJ, Deane R, Lynch DK, Ye ZS, Sanderson GM, Eyre HJ, Sutherland GR and Daly RJ. (2001). J. Biol. Chem., 276, 17172-17180.
25. Malinin NL, Boldin MP, Kovalenko AV and Wallach D. (1997). Nature, 385, 540-544.
26. Margolis B, Silvennoinen O, Comoglio F, Roonprapunt C, Skolnik E, Ullrich A and Schlessinger J. (1992). Proc. Natl. Acad. Sci. USA, 89, 8894-8898.
27. Matsushima A, Kaisho T, Rennert PD, Nakano H, Kurosawa K, Uchida D, Takeda K, Akira S and Matsumoto M. (2001). J. Exp. Med., 193, 631-636.
28. Nantel A, Huber M and Thomas DY. (1999). J. Biol. Chem., 274, 35719-35724.
29. Nantel A, Mohammad-Ali K, Sherk J, Posner BI and Thomas DY. (1998). J. Biol. Chem., 273, 10475-10484.
30. Obata H, Biro S, Arima N, Kaieda T, Eto H, Miyata M and Tanaka H. (1996). Biochem. Biophys. Res. Commun., 224, 27-32.
31. Ooi J, Yajnik V, Immanuel D, Gordon M, Moskow JJ, Buchberg AM and Margolis B. (1995). Oncogene, 10, 1621-1630.
32. Pawson T. (1995). Nature, 373, 573-580.
33. Reilly JF, Mickey G and Maher PA. (2000). J. Biol. Chem., 275, 7771-7778.
34. Sambrook J, Fritch EF and Maniatis T. (1989). Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.
35. Stein D, Wu J, Fuqua S, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow J, Buchberg A, Osborne C and Margolis B. (1994). EMBO J., 13, 1331-1340.
36. Sun L and Carpenter G. (1998). Oncogene, 16, 2095-2102.
37. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands J and Sugimachi K. (1997). Cancer Res., 57, 28-31.
38. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune KI, Wants JR and Sugimachi K. (1998). J. Clin. Invest., 102, 821-827.
39. Vaysssiere B, Zalcman G, Mache Y, Mirey G, Ligensa T, Weidner KM, Chardin P and Camonis J. (2000). FEBS Lett., 467, 91-96.
40. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin Jr AS. (1998). Science, 281, 1680-1683.
41. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV and Schreiber RD. (2001). Science, 291, 2162-2165.